John L. Magnani

2018

In 2018, John L. Magnani earned a total compensation of $1.6M as Chief Scientific Officer at GlycoMimetics, a 76% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$150,912
Option Awards$1,007,250
Salary$393,000
Other$5,447
Total$1,556,609

Magnani received $1M in option awards, accounting for 65% of the total pay in 2018.

Magnani also received $150.9K in non-equity incentive plan, $393K in salary and $5.4K in other compensation.

Rankings

In 2018, John L. Magnani's compensation ranked 6,981st out of 14,244 executives tracked by ExecPay. In other words, Magnani earned more than 51.0% of executives.

ClassificationRankingPercentile
All
6,981
out of 14,244
51st
Division
Manufacturing
2,682
out of 5,765
54th
Major group
Chemicals And Allied Products
1,010
out of 2,128
53rd
Industry group
Drugs
849
out of 1,817
53rd
Industry
Pharmaceutical Preparations
661
out of 1,391
53rd
Source: SEC filing on April 10, 2019.

Magnani's colleagues

We found three more compensation records of executives who worked with John L. Magnani at GlycoMimetics in 2018.

2018

Rachel King

GlycoMimetics

Chief Executive Officer

2018

Helen Thackray

GlycoMimetics

Chief Medical Officer

2018

Brian Hahn

GlycoMimetics

Chief Financial Officer

News

In-depth

You may also like